Model Number 3772MM |
Device Problem
Infusion or Flow Problem (2964)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 06/07/2015 |
Event Type
malfunction
|
Event Description
|
The nurse reports the patient with chronic obstructive pulmonary disease was to receive a nebulizer treatment with the uno opti-mist+ neb (opti-mist nebulizer).The nurse also reports the opti-mist nebulizer was attached to an oxygen source, oxygen was flowing through the patient's oxygen mask, the medication 'bubbled' in the nebulizer, however the treatment medication did not 'atomize'.It was also reported the patient received noninvasive ventilation treatment due to the failure of the opti-mist nebulizer.The nurse further adds the defective device was removed and a new functioning nebulizer was put in place and there was no harm to the patient.
|
|
Manufacturer Narrative
|
Based on the available information, this event is deemed a reportable malfunction.No further information was available at the time of the report.Additional patient/event details have been requested.There were no reports of the patient being harmed as a result of this malfunction.Should additional information become available, a follow-up report will be submitted.
|
|
Manufacturer Narrative
|
Additional information was received to clarify complaint details on (b)(6) 2015."these four products were not used on the same patient.It is four random products, all defective, and all used on different patients.The nurse could not remember the " story" about these specific products, because they have had so many defective nebulizers, so they just threw them away, but they kept some, because they have the serious case." these are four additional patients to the one that was reported in this complaint.Additional information was received on (b)(6) 2015.Returned product was received at the manufacturing site on (b)(6) 2015.Evaluation of this product is no longer required.The product was received and unable to be evaluated.No additional patient/event details have been provided to date.Should additional information become available, a follow-up report will be submitted.
|
|
Manufacturer Narrative
|
Previous investigation leveraged for this complain and the investigation is completed.Two root causes were identified.The jet was being produced in an old injection molding machine that was not conditioned with an alarm to detect and prevent the variation (double cycle) in the process.This machine has been discontinued.Inadequate inspection process for nebulizers.Corrective action has been implemented to include: verifying all active molding machines to confirm all have integrated the required alarms.Create a temporary quality alert to inspect nebulizer components every 2 hours as our inspection process is updated.Creation of a test method for inspection of molded components (nebulizer set and jet).Create a test method for inspection of molded components, clarify all details of process to do the mixing and add a form to record the amount of resin and material used in each mixing, determine water flow rates, water temperature and pressure, and include process parameters to be monitored.Determined the expected shelf life of pins for the orifice of cup and jet, and establish its replacement in the adequate period of time.No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.Reported to the fda on december 28, 2015.
|
|
Manufacturer Narrative
|
A quality complaint investigation was performed.One used sample was returned to assist with the investigation.The investigation performed by quality department of the manufacturing site indicated that product met the minimum aerosol output requirements at the lower air flow rate.It delivered 2.24ml.The evaluation of one used returned sample, indicated that no discrepancies were found.There is not enough information to conclude the product did not meet specification and perform as intended.Product monitoring reviews will monitor for product trends if this issue were to reoccur.No further actions are required, and the complaint will be closed.No additional patient/event details have been provided to date.Should additional information become available, a follow-up report will be submitted.Reported to the fda on august 04, 2015.
|
|
Search Alerts/Recalls
|
|